Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 20NET 11Gastrointestinal 5Thoracic 4Head & Neck 3Gynecologic 2Genitourinary 2Other solid neoplasm 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 1633Carcinoma, Renal Cell 502Urinary Bladder Neoplasms 462Carcinoma, Transitional Cell 234Breast Neoplasms 228Kidney Neoplasms 215Neoplasms 193Carcinoma, Non-Small-Cell Lung 172Colorectal Neoplasms 171Ovarian Neoplasms 163Melanoma 162Neoplasm Metastasis 143Lung Neoplasms 128Non-Muscle Invasive Bladder Neoplasms 105Pancreatic Neoplasms 103Stomach Neoplasms 101Uterine Cervical Neoplasms 92Squamous Cell Carcinoma of Head and Neck 85Endometrial Neoplasms 84Carcinoma, Hepatocellular 77Sarcoma 75Esophageal Neoplasms 72Head and Neck Neoplasms 70Triple Negative Breast Neoplasms 66Adenocarcinoma 66Colonic Neoplasms 53Testicular Neoplasms 52Disease 47Urologic Neoplasms 46Wilms Tumor 44

Interventions

cabozantinib 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoid Tumor × Genitourinary × 1 year × Clear all
NCT05263050 2026-05-22

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Fox Chase Cancer Center

Phase 2 Recruiting
111 enrolled
EndocrineGenitourinaryNET

Clear-cell metastatic renal cell carcinoma, Carcinoid Tumor, Carcinoma, Renal Cell, Neuroendocrine Tumors

NCT07389512 2026-02-05

PharmTRT

Hospices Civils de Lyon

Recruiting
600 enrolled
EndocrineGenitourinaryHead & Neck

Carcinoid Tumor, Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡